Shares of ArcBest (ARCB) plummeted 5.61% in pre-market trading on Monday, as analysts lowered their price targets on the company's stock, citing concerns about its future prospects.
In a research note released on Friday, J.P. Morgan cut its price target on ArcBest to $108 from $117, while Morgan Stanley slashed its target to $145 from $160. Wells Fargo also lowered its price target on the stock to $96 from $105.
The analysts' downgrades reflect concerns about the potential impact of macroeconomic factors on ArcBest's business performance. The transportation and logistics company has been grappling with rising costs and supply chain disruptions, which could weigh on its profitability in the coming quarters.
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。